Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder - Concepedia

Concepedia

Publication | Closed Access

Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder

622

Citations

0

References

2002

Year

John M. Kane, William H. Carson, Anutosh Ranjan Saha, Robert D. McQuade, Dan Zimbroff, Mirza W. Ali

The Journal of Clinical Psychiatry

Abstract

Aripiprazole, effective against positive and negative symptoms, is a safe and well-tolerated potential treatment for schizophrenia and schizoaffective disorder.